MedPath

Evaluation of Seelens AF, an Aspheric Intra-ocular Lens

Not Applicable
Withdrawn
Conditions
Cataract
Registration Number
NCT00825747
Lead Sponsor
Hanita Lenses
Brief Summary

Senile cataract is managed by cataract extraction and intra-ocular lens (IOL) implantation. The purpose of this study is to evaluate the safety and efficacy of the SeeLens AF, an acrylic hydrophilic aspheric IOL. This lens was designed to reduce vision aberrations and secondary cataract formation rate.

Preoperative evaluation: Best corrected visual acuity, refraction, comprehensive slit lamp examination and biometry.

Surgical procedure: Cataract surgery using a clear corneal incision (1.8mm to2.4mm), phacoemulsification and implantation of the SeeLens AF to the capsular bag. IOL implantation parameters will be evaluated by the surgeon.

Postoperative follow up: Best corrected visual acuity, uncorrected visual acuity, refraction and comprehensive slit lamp examinations up to 3 months after surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Senile Cataract
  • Age >18 years
  • Cataract extraction using phacoemulsification
  • Corneal incision less than 1.5 mm
Exclusion Criteria
  • Allergy/sensitivity to eye drops used during and after cataract surgery
  • Amblyopia/ strabismus
  • Ocular disease, other than cataract, diminishing visual acuity, such as corneal opacity, advanced glaucoma, diabetic retinopathy, exudative or moderate to severe non-exudative age-related macular degeneration, uveitis.
  • previous ocular surgery or ocular trauma in the investigated eye
  • Ocular anomaly, such as microphthalmos
  • Keratometry values less than 40 diopters or more than 47 diopters.
  • Ocular axial length less than 21.0 mm or longer than 25.0 mm
  • Intra-operative complications prior to intraocular lens implantation, such as tear of the posterior capsule.
  • posterior capsular scar
  • visual acuity in the fellow eye less than 20/200

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Best corrected visual acuity 3 months after SeeLens AF implantation3 months
Secondary Outcome Measures
NameTimeMethod
Complications related to SeeLens AF implantation during cataract surgery.3 months
Prediction of ocular refraction after cataract surgery with Seelens AF implantation3 months
Postoperative severe intra-ocular inflammation or infection3 months

Trial Locations

Locations (2)

Soroka University Medical Center

🇮🇱

Beer Sheva, Israel

Meir Medical Center

🇮🇱

Kfar-Saba, Israel

Soroka University Medical Center
🇮🇱Beer Sheva, Israel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.